UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure

American journal of ophthalmology, 2000-06, Vol.129 (6), p.723-727

2000

Volltextzugriff (PDF)

Twenty-four–hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination

Ophthalmology (Rochester, Minn.), 2003-07, Vol.110 (7), p.1357-1360

2003

Volltextzugriff (PDF)

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma : a six-month, masked, multicenter trial in the United States

Ophthalmology (Rochester, Minn.), 1996, Vol.103 (1), p.138-147

CAMRAS, C. B

1996

Volltextzugriff (PDF)

Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment

Journal of ocular pharmacology and therapeutics, 2004-12, Vol.20 (6), p.461-469

2004

Volltextzugriff (PDF)

Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma

American journal of ophthalmology, 1999-07, Vol.128 (1), p.15-20

1999

Volltextzugriff (PDF)

A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol

American journal of ophthalmology, 2002-06, Vol.133 (6), p.753-757

2002

Volltextzugriff (PDF)

Washout periods for brimonidine 0.2% and latanoprost 0.005

American journal of ophthalmology, 2001-06, Vol.131 (6), p.798-799

2001

Volltextzugriff (PDF)

Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005% timolol maleate 0.5% and dorzolamide 2% timolol maleate 0.5

Eye (London), 2004-12, Vol.18 (12), p.1264-1269

2004

Volltextzugriff (PDF)

Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy

Eye (London), 2004-10, Vol.18 (10), p.990-995

2004

Volltextzugriff (PDF)

Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma

American journal of ophthalmology, 2001-06, Vol.131 (6), p.729-733

2001

Volltextzugriff (PDF)

The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma

Eye (London), 2003-01, Vol.17 (1), p.41-46

2003

Volltextzugriff (PDF)

Intraocular pressure, safety, and quality of life in glaucoma patients switching to Latanoprost from monotherapy treatments

Journal of ocular pharmacology and therapeutics, 2003-10, Vol.19 (5), p.405-415

2003

Volltextzugriff (PDF)

Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension

American journal of ophthalmology, 2003-02, Vol.135 (2), p.138-143

2003

Volltextzugriff (PDF)

Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost

American journal of ophthalmology, 1999-12, Vol.128 (6), p.692-696

1999

Volltextzugriff (PDF)

Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005

American journal of ophthalmology, 2001-03, Vol.131 (3), p.339-344

2001

Volltextzugriff (PDF)

Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol

American journal of ophthalmology, 1998-09, Vol.126 (3), p.390-399

1998

Volltextzugriff (PDF)

Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma

Eye, 2000-02, Vol.14 (1), p.73-77

2000

Volltextzugriff (PDF)

Can patients guess their intraocular pressure?

American journal of ophthalmology, 2004-02, Vol.137 (2), p.350-351

2004

Volltextzugriff (PDF)

Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma

Eye (London), 2001-02, Vol.15 (1), p.59-62

2001

Volltextzugriff (PDF)

Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma

American journal of ophthalmology, 1999-02, Vol.127 (2), p.142-147

1999

Volltextzugriff (PDF)

Serum Lipid Physiology and the Influence of Glaucoma Medications

Survey of Ophthalmology, 1998-11, Vol.43 (3), p.233-244

1998

Volltextzugriff (PDF)

Cardiovascular Effects of Topical Carteolol Hydrochloride and Timolol Maleate in Patients With Ocular Hypertension and Primary Open-angle Glaucoma

American journal of ophthalmology, 1997-04, Vol.123 (4), p.465-477

1997

Volltextzugriff (PDF)

Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension

Journal of ocular pharmacology and therapeutics, 2000-12, Vol.16 (6), p.557-564

2000

Volltextzugriff (PDF)

The safety and efficacy of switching timolol maleate 0.5 % solution to timolol hemihydrate 0.5% solution given twice daily

Journal of ocular pharmacology and therapeutics, 1998-04, Vol.14 (2), p.129-135

1998

Volltextzugriff (PDF)

Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol

Journal of ocular pharmacology and therapeutics, 2002-06, Vol.18 (3), p.211-220

2002

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaEye

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(38)
Life Sciences & Biomedicine
(38)
Medical Sciences
(38)
Ophthalmology
(38)
Science & Technology
(38)
Pharmacology. Drug Treatments
(37)
Humans
(31)
Female
(24)
Glaucoma, Open-Angle - Drug Therapy
(24)
Male
(24)
Intraocular Pressure - Drug Effects
(22)
Middle Aged
(21)
Aged
(17)
Ocular Hypertension - Drug Therapy
(14)
Prospective Studies
(14)
Timolol - Therapeutic Use
(14)
Adrenergic Beta-Antagonists - Therapeutic Use
(11)
Prostaglandins F, Synthetic - Therapeutic Use
(11)
Cross-Over Studies
(10)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure

Twenty-four–hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma : a six-month, masked, multicenter trial in the United States

Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment

Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma

A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol

Washout periods for brimonidine 0.2% and latanoprost 0.005

Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005% timolol maleate 0.5% and dorzolamide 2% timolol maleate 0.5

Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy

Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma

The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma

Intraocular pressure, safety, and quality of life in glaucoma patients switching to Latanoprost from monotherapy treatments

Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension

Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost

Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005

Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol

Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma

Can patients guess their intraocular pressure?

Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma

Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma

Serum Lipid Physiology and the Influence of Glaucoma Medications

Cardiovascular Effects of Topical Carteolol Hydrochloride and Timolol Maleate in Patients With Ocular Hypertension and Primary Open-angle Glaucoma

Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension

The safety and efficacy of switching timolol maleate 0.5 % solution to timolol hemihydrate 0.5% solution given twice daily

Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol

Aktive Filter

Suchergebnisse filtern